CZO's work with the Angiogenesis Foundation was published in a top 3% scientific journal this week. Gilles had previously called the results a 'home run'. Dr. Li likened the potential to Intel Inside given the potential breadth of application across products. For those who haven't see this I asked Bing if the science of avenanthramide and beta glucan could be used together productively and synergistically.
Question:
Could these two treatments be used together productively or synergistically and what would the most promising applications be? "1% avenanthramide treatment promoted an extracellular matrix (ECM) architecture similar to unwounded skin, with shorter, more randomly aligned collagen fibers, and reduced inflammatory cell presence in the healed tissue. 1% β-Glucan treatment promoted a tissue architecture characterized by long, thick bundles of collagen with increased blood vessel density."
Bing's response:
Certainly! The combination of 1% avenanthramide treatment and 1% β-Glucan treatment could potentially yield synergistic effects, especially considering their distinct impacts on tissue architecture. Let’s explore the promising applications when these treatments are used together:
-
Wound Healing and Tissue Repair:
- Combining both treatments might enhance overall wound healing.
- Avenanthramide’s effect on ECM architecture (similar to unwounded skin) could work in tandem with β-Glucan’s promotion of long, thick collagen bundles and increased blood vessel density.
- Together, they could accelerate healing, improve tissue quality, and reduce scarring.
-
Chronic Wounds and Ulcers:
- Chronic wounds often involve impaired ECM and inadequate healing.
- Avenanthramide’s influence on collagen fibers and reduced inflammation could benefit chronic wound management.
- β-Glucan’s collagen-enhancing properties and improved blood vessel density might further aid in healing.
-
Dermatological Conditions:
- Skin disorders like eczema, psoriasis, or dermatitis could benefit from combined treatment.
- Avenanthramide’s skin-like ECM architecture and β-Glucan’s collagen support could address various skin issues.
-
Orthopedics and Bone Health:
- While the study focused on skin tissue, the collagen-related effects extend to bones.
- Combining treatments might enhance bone healing, especially in fractures or bone grafts.
- Improved blood vessel density could aid nutrient supply to bone tissues.
-
Cosmetic and Anti-Aging Applications:
- The collagen-related benefits align with cosmetic goals.
- Together, they could be used in anti-aging creams, scar reduction, or skin rejuvenation products.
-
Tissue Engineering and Regenerative Medicine:
- Researchers could explore using this combination in tissue scaffolds or implants.
- Avenanthramide and β-Glucan might synergistically enhance tissue regeneration.
Remember that while these applications are promising, further research and clinical trials are necessary to validate the effectiveness and safety of combining these treatments. Always consult with healthcare professionals before considering any new therapies or treatments.